Biotechnology Industry News

Though there are a set number of health conditions that can affect people, the actual effect they have can vary from one individual to another. This is because, though similar, every human is slightly different on the genetic level. Consequently, one treatment that works for one patient has no guarantee of working for another. With the realization of this fact, the medical specialty of personalized medicine has emerged, wherein the genetics of a person are studied to devise a suitable treatment. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample With extensive research and development (R&D), scientists have realized that a lot of diseases are caused by mutations in a particular gene, and if that particular gene is somehow deactivated, the disease could be managed. One of the ways it is being done is by artificially producing an antisense oligonucleotide, which is a single-strand deoxyribonucleic a

  Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample Two of the novel and most promising answers to cancer that such activities have yielded thus far are monoclonal antibodies (mAb) and proteins. To produce both these biopharmaceuticals, laboratories require something known as protein A resin. Thus, with the increasing focus on protein-based re